Generic competition · all medicines · read 12 November 2026

Is there a generic of Deutetrabenazine, and who makes it?

Deutetrabenazine appears in 2 dosage-form groups in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed. 2 groups have a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. Where both are dated, the first generic approval came 7.7 years after the first brand approval. This is the Orange Book's listing, not a forecast.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.

Not medical advice. This page reports what the FDA's Orange Book lists, not what a pharmacy has in stock, what anything costs, or whether a generic is right for you. Ask your pharmacist or prescriber about your own medicine.

Deutetrabenazine2 dosage-form groups in the Orange Book

0generic makers listed

Deutetrabenazine appears in 2 dosage-form groups in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed.
2 groups have a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
Where both are dated, the first generic approval came 7.7 years after the first brand approval.
Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.

Tablet, Extended Release, Oral

Brand listed, no generic listed as marketed

Brand listed as marketed: Austedo Xr. No generic is listed as marketed.

generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

3 April 2031Patent 8524733 drug substance
3 October 2031Patent 8524733*PED
18 September 2033Patent 9550780 drug substance
18 March 2034Patent 9550780*PED
7 March 2036Patent 12016858
7 March 2036Patent 10959996
7 March 2036Patent 11564917
7 March 2036Patent 11446291

15 more patents are listed.

Tablet, Oral

Brand listed, no generic listed as marketed

Brand listed as marketed: Austedo. No generic is listed as marketed (3 generic products listed as discontinued).

generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

3 April 2031Patent 8524733 drug substance
3 October 2031Patent 8524733*PED
18 September 2033Patent 9550780 drug substance
18 September 2033Patent 9233959 drug product
18 September 2033Patent 9296739 drug product
18 September 2033Patent 11666566 drug product
18 September 2033Patent 9814708 drug product
18 March 2034Patent 9233959*PED

20 more patents are listed.

US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.

Where can you go from this result?

Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.